Search for: "Novartis Vaccines and Diagnostics, Inc." Results 21 - 40 of 41
Sort by Relevance | Sort by Date
RSS Subscribe: 20 results | 100 results
12 Jul 2010, 9:59 pm by Patent Docs
By Donald Zuhn -- Last week, Novartis AG and Novartis Vaccines and Diagnostics, Inc. filed a complaint against U.S. [read post]
17 May 2010, 7:10 pm by mcarzima@imediainc.com
Novartis Vaccines & Diagnostics Inc. and Novartis Pharmaceuticals will pay $72.5 million to settle civil False Claims Act allegations that the company caused false claims to be submitted to federal health care programs through its marketing of the drug TOBI. [read post]
6 May 2010, 7:59 am by fraudfighters
Department of Justice announced that it had reached a settlement agreement with the drug company Novartis Vaccines & Diagnostics, Inc. [read post]
4 May 2010, 10:29 pm by Ben Vernia
According to DOJ’s press release: Novartis Vaccines & Diagnostics Inc. and Novartis Pharmaceuticals Corporation have agreed to pay $72.5 million to resolve civil False Claims Act allegations arising from the marketing of the cystic fibrosis drug TOBI, the Justice Department announced today. [read post]
25 Feb 2010, 6:30 am by Pilar G. Kraman
Novartis Vaccines and Diagnostics, Inc., C.A. [read post]
24 Feb 2010, 2:11 am
You can separately subscribe to the IP Think Tank Global Week in Review at the Subscribe page: http://duncanbucknell.com/subscribe/   Highlights this week included: EPO Enlarged Board of Appeal decides on dosage regime – Swiss-type claims no longer available: G 2/08 – Dosage Regime/Abbot Respiratory (EPLAW) (Managing Intellectual Property) (IPKat) (Patent Baristas) EPO Enlarged Board of Appeal rules on patenting a method of treatment by surgery: G1/07 (IPKat) (EPLAW) (Patent… [read post]
24 Feb 2010, 2:11 am
You can separately subscribe to the IP Think Tank Global Week in Review at the Subscribe page: http://duncanbucknell.com/subscribe/   Highlights this week included: EPO Enlarged Board of Appeal decides on dosage regime – Swiss-type claims no longer available: G 2/08 – Dosage Regime/Abbot Respiratory (EPLAW) (Managing Intellectual Property) (IPKat) (Patent Baristas) EPO Enlarged Board of Appeal rules on patenting a method of treatment by surgery: G1/07 (IPKat) (EPLAW) (Patent… [read post]
18 Dec 2009, 9:59 am by Karen E. Keller
(patent infringement) 12/10: Seattle Children's Hospital, Novartis AG, Novartis Vaccines and Diagnostics, Inc. and Novartis Pharmaceuticals Corporation v. [read post]
16 Dec 2009, 3:39 am
(Patent Docs) Crestor (Rosuvastatin) –US: AstraZeneca fails to win summary judgment in Crestor patent battle against Apotex and others (GenericsWeb) Cubicin (Daptomycin) – US: Trial date set Cubicin patent litigation against Teva (GenericsWeb) Effexor (Venlafaxine) – US: Settlement announced in Effexor XR patent infringement dispute between Pfizer and Mylan (Patent Docs) (BioSpace) Hexilate, Kogenate (Recombinant factor VIII) – US: Novartis Vaccines and… [read post]
27 Oct 2009, 8:28 am
Novartis Vaccines and Diagnostics, Inc., C.A. [read post]
27 Oct 2009, 12:47 am
Novartis Vaccines and Diagnostics Inc., 1-08-cv-00290 (DED October 23, 2009, Order) (Robinson, J.) [read post]
15 Sep 2009, 2:30 pm
" The vaccines are made by CSL Limited, MedImmune LLC, Novartis Vaccines and Diagnostics Limited, and sanofi pasteur Inc. [read post]
7 May 2009, 6:08 am
Novartis Pharmaceuticals Corp., 252 F.3d 986, 990 (8th Cir. 2001); Hans v. [read post]
22 Feb 2008, 6:00 pm
Signature Financial Group, Inc., and AT&T Corp. v. [read post]